Lilly Stock: Next Stop — Can Lilly Stock Reach $2,000?
Investors are watching Lilly stock: next stop as the company leverages obesity and diabetes drugs, while facing risin...
Understand the rationale behind cash back rewards on credit cards. Learn how to take advantage of these offers.
26,130 articlesInvestors are watching Lilly stock: next stop as the company leverages obesity and diabetes drugs, while facing risin...
The space-launch landscape is shifting as Blue Origin faces a setback. This could paradoxically amplify SpaceX's IPO ...
A six-pill prescription that would cost $1,000 in the United States ends up costing just $25 through an international...
Digital asset funds snapped a five-week bleed with a $1 billion inflow, led by Bitcoin and Ethereum, signaling a caut...
Amazon faced a string of severe outages that interrupted checkout, account data, and pricing. The company says it is ...
Piper Sandler trimmed its Upstart price target to $46 after a softer Q1 EBITDA print, but kept an Overweight rating a...
A DTCC collateral update did not blacklist XRP. The market briefly dumped XRP for other assets, but analysts say the ...
Regulatory clarity is heating up this summer. As Congress moves forward with the Clarity Act, Ethereum could emerge a...
A breakthrough announcement from OpenAI reshapes AI investing around Amazon. Learn what happened, why it matters, and...
Private-market real estate opens access to 25,000+ multifamily units as rents rise in low-supply markets, underscorin...
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
A recent filing shows Meros Investment Management sold a sizable block of Photronics shares. Learn what this kind of ...